Matt Teater

Dec 5, 2024 | cell.com | Yusuke Isshiki |Xi Chen |Matt Teater |Ioannis Karagiannidis |Winson Cai |Cem Meydan | +18 more

KeywordsEZH2T cell immunotherapyCAR-Tbispecific antibodiesfollicular lymphomaDLBCLGet full text accessLog in, subscribe or purchase for full access. References1. Schuster, S.J. ∙ Svoboda, J. ∙ Chong, E.A. ... Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasN. Engl. J. Med. 2017; 377:2545-25542. Locke, F.L. ∙ Miklos, D.B. ∙ Jacobson, C.A. ... Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell LymphomaN. Engl. J. Med. 2022; 386:640-6543. Bishop, M.R. ∙ Dickinson, M. ∙ Purtill, D. ...

Mar 7, 2024 | cell.com | Darko Barisic |Christopher R Chin |Cem Meydan |Matt Teater

Delmas V. Stokes D.G. Perry R.P. A mammalian DNA-binding protein that contains a chromodomain and an SNF2/SWI2-like helicase domain. Proc. Natl. Acad. Sci. USA. 1993; 90: 2414-2418https://doi.org/10.1073/pnas.90.6.2414Shen X. Mizuguchi G. Hamiche A. Wu C. A chromatin remodelling complex involved in transcription and DNA processing. Nature. 2000; 406: 541-544https://doi.org/10.1038/35020123Tsukiyama T. Daniel C. Tamkun J. Wu C.